Medicament for treating hepatic cirrhosis with hypoproteinemia after hepatitis
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A low-protein technology for post-hepatitis cirrhosis, applied in drug combination, digestive system, blood diseases, etc., can solve the problems of heavy patient burden and expensive albumin drugs
Inactive Publication Date: 2009-04-15
李艳
View PDF0 Cites 13 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
At present, the Western medicine treatment of hypoalbuminemia mainly relies on infusion of albumin and improvement of liver function. However, clinically, the price of albumin is expensive and the burden on patients is heavy. Hypoproteinemia is also difficult to correct
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0014] Weigh the raw materials (grams) according to the following proportioning ratio:
[0024] The preparation method is as follows: decoct in water.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses a medicine for treating cirrhosis hypoproteinemia after hepatitis. The medicine is a medicine preparation prepared from traditional Chinese medicine materials in weight portion: 25 to 35 portions of radix astragali, 10 to 20 portions of codonopsis pilosula, 10 to 20 portions of donkey-hide gelatin, 15 to 25 portions of angelica, 10 to 20 portions of radices paeoniae alba, 10 to 20 portions of radix rehmanniae, 25 to 35 portions of salvia miltiorrhiza, 30 to 100 portions of rhizoma atractylodis alba, 5 to 15 portions of radices saussureae, 5 to 15 portions of medlar, 10 to 90 portions of radices paeoniae rubra, 25 to 35 portions of fructus polygoni orientalis, 10 to 20 portions of pseudostellariae, 5 to 15 portions of carapax amydae, 5 to 15 portions of radix bupleuri, 5 to 15 portion of concha arcae, 15 to 30 portions of tuckahoe, 5 to 15 portions of fried fructus oryzae germinatus and 5 to15 portions of radices zedoariae. Through clinical verification, the medicine has the characteristics of mature technology, safety, reliability, less poor reaction, tolerance by patients, low price and the like, is convenient to popularize and apply, and has wide application prospect.
Description
technical field [0001] The invention relates to a Chinese patent medicine for treating liver diseases. Background technique [0002] The liver is a place for protein synthesis, and the ability to synthesize proteins in liver cirrhosis after hepatitis decreases, resulting in hypoalbuminemia. At present, the Western medicine treatment of hypoalbuminemia mainly relies on infusion of albumin and improvement of liver function. However, clinically, the price of albumin is expensive and the burden on patients is heavy. Hypoproteinemia is also difficult to correct. Contents of the invention [0003] The task of the present invention is to provide a medicine for treating post-hepatitis cirrhosis hypoalbuminemia. [0004] Its technical solutions are: [0005] A kind of medicine for the treatment of posthepatitis cirrhosis hypoalbuminemia, the medicament that is made of following Chinese medicine raw material: (consumption is weight part) [0006] Astragalus 30-90, Codonopsis 10-...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more